O99.891

O99.891: Other specified diseases and conditions complicating pregnancy

Billable / specific codeICD-10-CM

O99.891 is a billable, specific ICD-10-CM code for other specified diseases and conditions complicating pregnancy. It is valid for submission on a claim.

Check O99.891 with the rest of the claim: free scrubber

Excludes2 inherited from the categories above O99.891

Not part of this code, but both may be coded when both are present.

Written on O99.8: Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

genitourinary infections in pregnancy (O23.-)
infection of genitourinary tract following delivery (O86.1-O86.4)
malignant neoplasm complicating pregnancy, childbirth and the puerperium (O9A.1-)
maternal care for known or suspected abnormality of maternal pelvic organs (O34.-)
postpartum acute kidney failure (O90.49)
traumatic injuries in pregnancy (O9A.2-)

Written on O99: Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

when the reason for maternal care is that the condition is known or suspected to have affected the fetus (O35-O36)

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

O99.891 is named in 1 Medicare coverage policy: 1 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A56686Billing and Coding: HbA1c

Alphabetic index entries that lead here

Pregnancy›complicated by›connective system disorders(conditions in M00-M99)
Pregnancy›complicated by›musculoskeletal condition(conditions is M00-M99)
Pregnancy›complicated by›pelvic inflammatory disease
Pregnancy›complicated by›peritoneal adhesions(pelvic)
Pregnancy›complicated by›diseases of›specified NEC
Pregnancy›complicated by›disorders of›ear and mastoid process(conditions in H60-H95)
Pregnancy›complicated by›disorders of›eye and adnexa(conditions in H00-H59)
Pregnancy›complicated by›disorders of›specified NEC

Code history

Unchanged in every release from FY2024 to FY2027.